# A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke

Study · id `cardio:ct-nct05355948` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05355948](<https://clinicaltrials.gov/study/NCT05355948>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05355948

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

## Technical summary

Registry record NCT05355948. Randomized; no masking; primary purpose prevention. Start 2022-05-09 (actual); primary completion 2023-07-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1000 participants (enrolled count; ClinicalTrials.gov record NCT05355948, source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)
- Started: 2022-05-09 (actual) (ClinicalTrials.gov record NCT05355948, source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)
- Primary completion: 2023-07-31 (actual) (ClinicalTrials.gov record NCT05355948, source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)
- Completion: 2024-07-31 (actual) (ClinicalTrials.gov record NCT05355948, source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT05355948, source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05355948-2026-07-01`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke
- Acronym: MEMO-DAF8
- Condition: Atrial Fibrillation/Flutter in Patients With High Risk of Stroke
- Intervention (Device): MEMO Patch PLUS for 1 day
- Intervention (Device): MEMO Patch PLUS for More than 8-days
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: 4ad180f7ff41aab3eff94b3892b68b6a8018a18b29c89a960a1010ea0e474286
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
